Telehealth Rules and Pharmacy Marketing, Explained
What telehealth changes, and what it does not
- Telehealth
- The delivery of health services and clinical evaluation using telecommunications technology, where the patient and clinician are in different locations. 1
Telehealth changes the channel of care. It does not remove the requirement for a legitimate clinical relationship and evaluation behind a prescription. The U.S. Department of Health and Human Services explains that telehealth is governed by a mix of federal rules and state law, and that licensing and practice standards still apply. 1 In other words, "online" does not mean "no evaluation."
- Synchronous visit
- A real-time, two-way interaction between patient and clinician (for example, live video or phone), as distinct from asynchronous methods like a questionnaire reviewed later. Some states and programs treat these differently. 13
State boards set the specifics
Whether a synchronous visit is required, what counts as establishing a prescriber-patient relationship, and which medications carry extra rules are largely decided by state medical and pharmacy boards. The Federation of State Medical Boards has published telemedicine policy guidance describing the expectation of a proper evaluation before treatment, and individual state boards adopt their own binding rules. 3 Because those rules vary, the same telehealth flow can be acceptable in one state and not in another.
Why the FTC cares about telehealth claims
The Federal Trade Commission has taken action against telehealth and direct-to-consumer health marketing it viewed as deceptive, including matters involving how medications were advertised and how recurring charges were disclosed. 2 The throughline is familiar: claims must be truthful and substantiated, material terms must be clear, and consumers should not be misled about what they are signing up for. 2 Telehealth does not get a lighter standard.
What this means for pharmacy and clinic marketing
- Do not promise or guarantee a prescription. The prescriber decides after an evaluation. 13
- Do not frame the clinical visit as a formality or imply you can skip a real evaluation. 3
- Be honest about what a partner telehealth service does and does not provide. 2
- Disclose material terms clearly, including any recurring charges or subscription structure. 2
- Avoid outcome promises and "get medication X online fast" framing. 2
- Keep claims truthful and supportable, and have counsel review the funnel. 2
A cleaner approach is to market the category of care and the quality of the experience in general terms, and to let the licensed clinician own the clinical decision. That keeps the message honest and keeps the pharmacy out of the position of advertising an outcome it cannot promise.
This is an educational summary, not legal advice, and telehealth rules change often and differ by state. Confirm current requirements with the relevant state medical and pharmacy boards and with qualified counsel before relying on any telehealth marketing approach. 123
This is how compound.BUZZ thinks about compliant compounding pharmacy marketing. See the full done-for-you system built only for independent compounding pharmacies.
Frequently asked questions
Does telehealth let a patient get a prescription without a real evaluation?
No. A valid prescription still depends on a legitimate prescriber-patient relationship and evaluation. Telehealth changes the channel, not the underlying requirement, and state boards set the specifics. Marketing should not imply otherwise.
Can a pharmacy advertise that customers can get a medication through an online visit?
Be very careful. Implying a guaranteed or fast path to a specific medication can be misleading and can run into FTC scrutiny, because the prescriber decides after an evaluation. It is safer to describe the category of care in general terms and let the clinician own the decision.
Are synchronous video visits always required?
It depends on the state and sometimes the medication. Some states and programs distinguish synchronous from asynchronous care and set different rules. Check the relevant state medical and pharmacy board requirements.
Sources
- U.S. Department of Health and Human Services (Telehealth.HHS.gov). Telehealth policy, licensing, and prescribing basics
- U.S. Federal Trade Commission. FTC actions and guidance on deceptive telehealth and health marketing
- Federation of State Medical Boards. Telemedicine policy guidance (evaluation and prescriber-patient relationship)
This article is educational and reflects a third-party summary of public sources. It is not medical, clinical, legal, or pharmaceutical advice, and makes no claim about any medication. Verify current state and federal rules before acting. compound.BUZZ is a marketing service of Buzzword Strategies LLC.